Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

We examined how age-related patterns of cocaine and methamphetamine use vary by sexual identity and gender among a national sample.

Original research | 2022
About PWUD, Illegal drugs, 2SLGBTQI+, Stimulants

This study identified patient clinical and sociodemographic characteristics, and, more originally, service use patterns as predictors of death from physical illness or accidental/intentional causes

Original research | 2022
Mortality, About PWUD

This review aimed to assess the application and effectiveness of digital interventions to treat opioid use disorder globally.

Lit review | 2022
Digital health, About PWUD
Guide or handbook | 2021
SCS/OPS, Harm reduction, Policy/Regulatory, Illegal drugs
Rapport | 2022
la surdose, la mortalité
Report | 2022
Overdose, Mortality

Racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients.

Original research | 2022
Equity, Barriers and enablers, About PWUD, Substitution/OAT

To understand patient experience of federal regulatory changes governing methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic.

Original research | 2022
Policy/Regulatory, About PWUD, Substitution/OAT, Carries/take-home doses
Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance
Guide or handbook | 2022
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers

The objective of this analysis was to measure rates of follow-up and use of medications for OUD (MOUD) after residential treatment among Medicaid enrollees in 10 states, and to understand the enrol

Original research | 2022
Transitions in care/treatment, Substitution/OAT, Wrap-around services

Health Canada conditionally approves new drugs using its Notice of Compliance with conditions (NOC/c) policy.

Original research | 2022
Policy/Regulatory
Letter | 2022
Safer supply, About prescribers, Policy/Regulatory, Overdose

Racial/ethnic minorities have experienced disproportionate opioid-related overdose death rates in recent years.

Original research | 2022
Overdose, Harm reduction, Equity

Buprenorphine is an effective medication for the treatment of opioid use disorder (OUD), but the association between prior authorization policies and quality of care for individuals receiving bupre

Original research | 2022
Policy/Regulatory, Substitution/OAT

To estimate the association between buprenorphine treatment gaps, opioid overdose, and health care spending.

Original research | 2022
Overdose, Substitution/OAT, About PWUD

The objectives of this study were to assess the prevalence and correlates of naloxone administration by police, as well as to examine overdose events where arrests were made and those in which the

Original research | 2022
Legal system/law enforcement, Overdose

We examined the impact of U.S. state opioid-prescribing policies on opioid overdose mortality following implementation.

Original research | 2022
About prescribers, Mortality, Policy/Regulatory, Legal system/law enforcement

We sought to examine the relationship between OAT engagement and crystal methamphetamine use and to assess if this relationship differs according to the ongoing use of unregulated opioids.

Original research | 2022
Substitution/OAT, Stimulants, Illegal drugs, About PWUD, Transitions in care/treatment

Affiner votre recherche

Mots clés
Format
Région